Literature DB >> 6079203

Fibrinolysis in subarachnoid haemorrhage.

J R Gibbs, P O'Gorman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6079203      PMCID: PMC2466423          DOI: 10.1136/pgmj.43.506.779

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

1.  Further observations on subarachnoid haemorrhage.

Authors:  W McKISSOCK; K PAINE; L WALSH
Journal:  J Neurol Neurosurg Psychiatry       Date:  1958-11       Impact factor: 10.154

2.  Discussion on the early management of subarachnoid haemorrhage.

Authors:  J M HOLMES; R A HENSON; J M SMALL
Journal:  Proc R Soc Med       Date:  1957-04

3.  Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis.

Authors:  G R FEARNLEY; G BALMFORTH; E FEARNLEY
Journal:  Clin Sci       Date:  1957-11       Impact factor: 6.124

4.  The late prognosis of subarachnoid haemorrhage.

Authors:  J N WALTON
Journal:  Br Med J       Date:  1952-10-11

5.  Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations.

Authors:  H B Locksley
Journal:  J Neurosurg       Date:  1966-09       Impact factor: 5.115

6.  COAGULATION AND FIBRINOLYSIS IN INJURED PATIENTS.

Authors:  D INNES; S SEVITT
Journal:  J Clin Pathol       Date:  1964-01       Impact factor: 3.411

  6 in total
  14 in total

Review 1.  On Aneurysmal Rupture and Rerupture.

Authors:  Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2018-10       Impact factor: 3.210

2.  Biochemical changes after spontaneous subarachnoid haemorrhage. 3. Coagulation and lysis with special reference to recurrent haemorrhage.

Authors:  A H Uttley; M Buckell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-12       Impact factor: 10.154

Review 3.  Antifibrinolytic agents in subarachnoid haemorrhage.

Authors:  K W Lindsay
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

4.  Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms.

Authors:  J R Gibbs; A G Corkill
Journal:  Postgrad Med J       Date:  1971-04       Impact factor: 2.401

5.  Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid.

Authors:  S A Tsementzis; W P Honan; S Nightingale; E R Hitchcock; C H Meyer
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 6.  Antifibrinolytic treatment in subarachnoid haemorrhage: present state.

Authors:  H Fodstad
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

7.  Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).

Authors:  H Fodstad; I M Nilsson
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

8.  Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: a retrospective clinical study.

Authors:  G Pinna; A Pasqualin; C Vivenza; R Da Pian
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

9.  Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.

Authors:  H Fodstad
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

10.  Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding?

Authors:  R S Maurice-Williams; Y B Gordon; A Sykes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.